View in EDS

Belzutifan efficacy in von Hippel-Lindau disease-associated renal cell carcinoma versus natural history control arm.

Saved in:
Bibliographic Details
Title: Belzutifan efficacy in von Hippel-Lindau disease-associated renal cell carcinoma versus natural history control arm.
Authors: Linehan WM; Urologic Oncology Branch, National Cancer Institute, Bethesda, MD, United States., Jemielita T; Biostatistics and Research Decision Sciences, Merck & Co., Inc, Rahway, NJ, United States., Cornell J; Biostatistics and Research Decision Sciences, Merck & Co., Inc, Rahway, NJ, United States., Chen K; Biostatistics and Research Decision Sciences, Merck & Co., Inc, Rahway, NJ, United States., Ball MW; Urologic Oncology Branch, National Cancer Institute, Bethesda, MD, United States., Srinivasan R; Urologic Oncology Branch, National Cancer Institute, Bethesda, MD, United States., Liu Y; Clinical Research, Merck & Co., Inc, Rahway, NJ, United States., Perini RF; Clinical Research, Merck & Co., Inc, Rahway, NJ, United States., Pinto CA; Biostatistics and Research Decision Sciences, Merck & Co., Inc, Rahway, NJ, United States.
Source: Journal of the National Cancer Institute [J Natl Cancer Inst] 2026 Jun 01; Vol. 118 (6), pp. 1081-1088.
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41964905
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Belzutifan efficacy in von Hippel-Lindau disease-associated renal cell carcinoma versus natural history control arm.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Linehan+WM%22">Linehan WM</searchLink>; Urologic Oncology Branch, National Cancer Institute, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Jemielita+T%22">Jemielita T</searchLink>; Biostatistics and Research Decision Sciences, Merck & Co., Inc, Rahway, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Cornell+J%22">Cornell J</searchLink>; Biostatistics and Research Decision Sciences, Merck & Co., Inc, Rahway, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Chen+K%22">Chen K</searchLink>; Biostatistics and Research Decision Sciences, Merck & Co., Inc, Rahway, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Ball+MW%22">Ball MW</searchLink>; Urologic Oncology Branch, National Cancer Institute, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Srinivasan+R%22">Srinivasan R</searchLink>; Urologic Oncology Branch, National Cancer Institute, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; Clinical Research, Merck & Co., Inc, Rahway, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Perini+RF%22">Perini RF</searchLink>; Clinical Research, Merck & Co., Inc, Rahway, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Pinto+CA%22">Pinto CA</searchLink>; Biostatistics and Research Decision Sciences, Merck & Co., Inc, Rahway, NJ, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227503089%22">Journal of the National Cancer Institute</searchLink> [J Natl Cancer Inst] 2026 Jun 01; Vol. 118 (6), pp. 1081-1088.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7503089 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1460-2105 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200278874%22">00278874 </searchLink><i>NLM ISO Abbreviation: </i>J Natl Cancer Inst <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41964905
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/jnci/djag064
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1081
    Titles:
      – TitleFull: Belzutifan efficacy in von Hippel-Lindau disease-associated renal cell carcinoma versus natural history control arm.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Linehan WM
      – PersonEntity:
          Name:
            NameFull: Jemielita T
      – PersonEntity:
          Name:
            NameFull: Cornell J
      – PersonEntity:
          Name:
            NameFull: Chen K
      – PersonEntity:
          Name:
            NameFull: Ball MW
      – PersonEntity:
          Name:
            NameFull: Srinivasan R
      – PersonEntity:
          Name:
            NameFull: Liu Y
      – PersonEntity:
          Name:
            NameFull: Perini RF
      – PersonEntity:
          Name:
            NameFull: Pinto CA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2026 Jun 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1460-2105
          Numbering:
            – Type: volume
              Value: 118
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Journal of the National Cancer Institute
              Type: main
ResultId 1